WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60


Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here


Track Your Article



Dr. Monica Tararam Hume* and Dr. Gunvant H. Yeola


Muscular dystrophy is a group of disorders characterized by a progressive loss of muscle mass and consequent loss of strength may affect up to 1 in 3500 males. The most common form of muscular dystrophy is Duchenne Muscular Dystrophy (DMD)– typically affect young boys, but other variations can strike in adulthood. Other type is Becker Muscular Dystrophy (BMD) – similar symptoms to Duchenne but with a later onset and slower progression. Patient usually becomes wheelchair bound by the age of 8 to 10 years, and a proportion of patients have mental sub-normality and cardiac abnormalities. Among which some die of cardio-respiratory complications in their late teens to early twenties. Currently there is no cure for muscular dystrophy, but certain physical and medical treatments can improve symptoms and slow the disease progression such as corticosteroids, physical therapy, respiration assistance, gene therapy and heart medication such as beta blocker.

Keywords: Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD), Ayurved treatment, Shosha, Mamsagata vata.

[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More